trending Market Intelligence /marketintelligence/en/news-insights/trending/S0k7WKCB5feLP3xYJJ4cog2 content esgSubNav
In This List

Cellect Biotechnology appoints directors

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Cellect Biotechnology appoints directors

Cellect Biotechnology Ltd. appointed David Braun and Ruhama Avraham directors of the company.

Braun's term will last until the Israel-based company's next annual general meeting. Avraham will served as an external director for a three-year term ending Dec. 12, 2020.

Braun previously served as head of medical device business at Merck KGaA. Avraham is an external director of Minrav Holdings Ltd. and previously served as Israel's minister of tourism.